Skip to content
Open access

Major depressive disorder recurrence and medication status shape brain network topology

Sep 2026 · bioRxiv · 0 citations · 68 references
Biology

TL;DR

Findings indicate that MDD is associated with altered multiscale functional organization, combining less compact global integration with an increased prevalence of cross-network hole-defining cycles, with these features varying systematically with illness course and current medication, suggesting that topology-informed measures capture clinically relevant variability in brain organization in depression.

Abstract

Introduction Major depressive disorder (MDD) is a highly prevalent and disabling psychiatric disorder. Human neuroimaging studies increasingly frame its neurobiological substrate in terms of alterations of large-scale brain network organization. Resting-state fMRI findings broadly align with this view, yet remaining highly heterogeneous, reflecting both clinical and analytic variability. Predominant approaches largely characterize functional organization in terms of pairwise relationships between regions, which may limit the ability to capture more global features of brain organization associated with depression and its course. Here we use novel methods from Topological Data Analysis to provide new perspectives on these brain-behavior associations Objectives The main objective of this study was to determine whether whole-brain topological descriptors of functional connectivity capture alterations associated with MDD. In particular, we examined whether these features vary along clinically relevant dimensions of heterogeneity, focusing on illness course (single-episode vs. recurrent MDD) and current antidepressant medication status. To this end, we analyzed the area under the curve (AUC) of the zeroth and first Betti numbers (B₀ and B₁), which index global network integration and higher-order cycle structure across scales, respectively. Methods Neuroimaging (resting state fMRI) and phenotypic data were obtained from 1,490 participants (776 individuals with MDD and 714 never-depressed controls) included in the REST-meta-MDD project of the DIRECT consortium. Functional connectivity matrices were computed using Pearson correlations between regions defined by the Power-264 atlas and harmonized across sites using CovBat. Topological Data Analysis was applied to characterize whole-brain network organization across connectivity thresholds using B₀ and B₁ curves and their areas under the curve (AUC). B₁ associated cycle counts and their coarse anatomical configurations were further examined. Group differences and effects of illness course and medication status were assessed using multiple linear and generalized linear regression models. Results Compared with controls, individuals with MDD showed significantly higher B₀ AUC, indicating altered global integration profiles across connectivity thresholds. B₀ AUC did not differ by illness course, illness duration, or symptom severity. In contrast, B₁ AUC showed a graded increase across illness courses, with the highest values observed in recurrent depression. This effect was driven by an increased number of one-dimensional cycles rather than greater cycle persistence. Medication status further modulated B₁ alterations, with elevated values observed in unmedicated single-episode and medicated recurrent MDD. Anatomical decomposition revealed that higher-order alterations were primarily driven by inter-network configurations spanning multiple large-scale functional systems. Discussion These findings indicate that MDD is associated with altered multiscale functional organization, combining less compact global integration with an increased prevalence of cross-network hole-defining cycles, with these features varying systematically with illness course and current medication, suggesting that topology-informed measures capture clinically relevant variability in brain organization in depression.

Read PDF

Similar papers

Open access Oct 2026

Temporal organization of shared brain states characterizes heterogeneity in major depressive disorder

Major depressive disorder (MDD) is biologically heterogeneous, but how this variability is expressed in the temporal organization of brain activity remains unclear. Using resting-state functional MRI from 2,225 participants, we applied hidden Markov modeling to identify recurrent brain states and quantify their tempora...

Chun-Yu Pan, Yue Tu, Fei Wang et al. · 0 citations
Sep 2026

Modeling inter-subject heterogeneity improves multisite rs-fMRI identification of major depressive disorder: An interpretable graph neural network approach.

BACKGROUND Major depressive disorder (MDD) is a highly heterogeneous affective disorder, and the identification of reliable neuroimaging markers remains challenging. Resting-state functional magnetic resonance imaging offers a promising approach for characterizing altered brain functional organization in MDD. However,...

Ting Mei, Man-Yun Zhu, Hongbo Zhu et al. · 0 citations
Sep 2026

Cognitive heterogeneity in major depressive disorder: Neuroimaging, transcriptomic, and neurotransmitter profiles.

This study provides a data-driven characterization of cognitive heterogeneity in MDD, identifying two cognitive dimensions spanning from relative preservation to widespread impairment, and provides preliminary biological context for interpreting cognitive heterogeneity in MDD.

Yu-Shun Yan, Jia'ao Yu, L. Zuo et al. · 0 citations
Open access Sep 2026

306. Genetic and neuroimaging correlates of symptom severity in major depressive disorder: an imaging–genetics study

Findings indicate that individual variations in habenula-centered circuits are partly shaped by gene polymorphisms related to mood and circadian regulation and contribute to the symptom heterogeneity of depression.

M. Kim, J.-Y. Jung, S.-J. Cho et al. · 0 citations
Sep 2026

Distinct pattern in bipolar depression and major depressive disorder: A multiscale imaging-transcriptomic analysis.

These findings identify distinct cortical morphometric organization in BDD and MDD, and these differences are linked to transcriptomic, cellular, and neurotransmitter-related annotations, providing multiscale insights into the neurobiological divergence between the two disorders.

Guang-Wei Sun, Tai-Peng Sun, Yu-Cheng Yuan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.